Companies / Crystalys Therapeutics

Crystalys Therapeutics

San Diego, United States

Crystalys Therapeutics develops new therapeutics to address unmet medical needs, specifically for people living with gout.

Healthcare & Biotech

Crystalys Therapeutics, based in San Diego, United States, has 11 investors on file, among them AN Venture Partners, Catalys Pacific and Frazier Life Sciences. Its latest round on record is Series B, 22 Jul 2026, of 2 rounds. Its site was last checked 12 Nov 2026: site answers.

crystalystx.com

Funding

2 rounds on record

Latest roundSeries B22 Jul 2026

Since that round4 monthsno later round on record

Time between rounds10 monthson average, over 2 rounds

Investors in its rounds2111 with a VCinfo profile

Jul 2026Series BLed by Frazier Life Sciences, with Xontogeny, Pontifax, Catalys Pacific, AN Venture Partners, SBI Investment Korea, Longwood Fund, SR One, Lightstone Ventures, Soleus Capital, Pivotal Life Sciences and 10 others

Sept 2025Series ALed by Novo Holdings, with SR One, SBI Investment Korea, Lightstone Ventures, Longwood Fund, Catalys Pacific, Xontogeny, AN Venture Partners, Pontifax and 4 others

Round sizes and total raised are on Fundup AI, our sister product for funding data.

Investors

11 investors on file

Investor	Evidence	Type
AN Venture Partners	Page + round	Venture capital
Catalys Pacific	Portfolio page	Venture capital
Frazier Life Sciences	Page + round	Venture capital
Lightstone Ventures	Page + round	Venture capital
Longwood Fund	Portfolio page	Venture capital
Pivotal Life Sciences	Portfolio page	Venture capital
Pontifax	Page + round	Venture capital
SBI Investment Korea	Portfolio page	Venture capital
Soleus Capital	Portfolio page	Venture capital
SR One	Page + round	Venture capital
Xontogeny	Page + round	Accelerator

A company is shown only after its own site answers and carries its name. Sites are checked again on a schedule, because domains lapse and get bought. Round stages and dates come from Fundup AI; investor links come from portfolio pages and rounds; other facts name their source when you point at them. How we grade the data

At a glance

Latest round: Series B, 22 Jul 2026
Investors on file: 11
Founded: 2025
Employees: 11-50
Headquarters: San Diego, United States
Site: Answers
Last checked: 12 Nov 2026

Company data by Fundup AI.

Backed by the same investors

Companies sharing two or more investors with Crystalys Therapeutics.

Avalyn3 shared

Parabilis Medicines3 shared

Addition Therapeutics2 shared

Airnexis Therapeutics2 shared

Arcutis2 shared

Bicycle Therapeutics2 shared

Get this company as JSON

GET /v1/companies/crystalystx.com
GET /v1/companies/crystalystx.com/investors
GET /v1/companies/crystalystx.com/news

API docs · Get a free key · Your API key

Raising a round?

See which investors fit your startup, ranked by what they actually back.

Check investor fit

Free account · no card

Get Crystalys Therapeutics and its investors as data

Look up any company's investors, or any investor's full portfolio, through one API key or MCP. A free account also opens Ask AI searches and alerts when AN Venture Partners adds a company.

Work email, sign-in link by email. Already have an account? Log in

Your API key Read the docs

Ask AI5 plain-English investor searches a day
Full listsEvery portfolio row and two-firm overlap
API and MCP100 REST or MCP calls a month, one key
AlertsFollow 5 investors for portfolio and fund changes

VCinfo API

$ curl -H "X-API-Key: YOUR_KEY" \
  https://api.vcinfo.io/v1/companies/crystalystx.com/investors

# also
GET /v1/companies/crystalystx.com
GET /v1/companies/crystalystx.com/news

The same data as an MCP server for Claude, Cursor and other AI tools. Set up MCP · Docs · Pricing